Mitchell Eggers1, Serge Rousselle2, Mark Urtz3, Rhonda Albright3, Alice Will3, Bettina Jourden3, Cynthia Godshalk4, Stephen Dria5, Steven Huang6, Joseph Steele6. 1. Adient Medical, 2315 Delta Bridge Dr, Pearland, TX 77854; University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address: mitcheggers@yahoo.com. 2. Alizee Pathology, Thurmont, Maryland. 3. Synchrony Labs, Durham, North Carolina. 4. East Coast Veterinary Imaging, Stuart, Florida. 5. Adient Medical, 2315 Delta Bridge Dr, Pearland, TX 77854. 6. University of Texas M.D. Anderson Cancer Center, Houston, Texas.
Abstract
PURPOSE: To compare the safety and efficacy of an absorbable inferior vena cava (IVC) filter and a benchmark IVC filter in a porcine model. MATERIALS AND METHODS: A randomized controlled Good Laboratory Practice study was performed in Domestic Yorkshire cross swine. Sixteen swine were implanted with an absorbable IVC filter (test device; Adient Medical, Pearland, Texas); 8 were implanted with a benchmark metal IVC filter (control device; Cook Medical, Bloomington, Indiana). All animals underwent rotational digital subtraction pulmonary angiography and cavography (anteroposterior and lateral) before filter deployment and 5 and 32 weeks after deployment. Terminal procedures and necropsy were performed at 32 weeks. The IVC, heart, lungs, liver, and kidneys were harvested at necropsy. The reported randomized controlled GLP animal study was conducted at Synchrony Labs, Durham, North Carolina. RESULTS: One animal died early in the test cohort of a recurring hemorrhage at the femoral access site resulting from a filter placement complication. All other animals remained clinically healthy throughout the study. No pulmonary embolism was detected at the 5- and 32-week follow-up visits. The absorbable filter subjects experienced less caval wall perforation (0% vs 100%) and thrombosis (0% vs 75%). The control device routinely perforated the IVC and occasionally produced collateral trauma to adjacent tissues (psoas muscle and aorta). The veins implanted with the absorbable filter were macroscopically indistinguishable from normal adjacent veins at 32 weeks except for the presence of radiopaque markers. Nontarget tissues showed no device-related changes. CONCLUSIONS: Implantation of the absorbable IVC filter in swine proved safe with no pulmonary emboli detected. There was complete to near-complete resorption of the filter polymer by 32 weeks with restoration of the normal appearance and structure of the IVC.
PURPOSE: To compare the safety and efficacy of an absorbable inferior vena cava (IVC) filter and a benchmark IVC filter in a porcine model. MATERIALS AND METHODS: A randomized controlled Good Laboratory Practice study was performed in Domestic Yorkshire cross swine. Sixteen swine were implanted with an absorbable IVC filter (test device; Adient Medical, Pearland, Texas); 8 were implanted with a benchmark metal IVC filter (control device; Cook Medical, Bloomington, Indiana). All animals underwent rotational digital subtraction pulmonary angiography and cavography (anteroposterior and lateral) before filter deployment and 5 and 32 weeks after deployment. Terminal procedures and necropsy were performed at 32 weeks. The IVC, heart, lungs, liver, and kidneys were harvested at necropsy. The reported randomized controlled GLP animal study was conducted at Synchrony Labs, Durham, North Carolina. RESULTS: One animal died early in the test cohort of a recurring hemorrhage at the femoral access site resulting from a filter placement complication. All other animals remained clinically healthy throughout the study. No pulmonary embolism was detected at the 5- and 32-week follow-up visits. The absorbable filter subjects experienced less caval wall perforation (0% vs 100%) and thrombosis (0% vs 75%). The control device routinely perforated the IVC and occasionally produced collateral trauma to adjacent tissues (psoas muscle and aorta). The veins implanted with the absorbable filter were macroscopically indistinguishable from normal adjacent veins at 32 weeks except for the presence of radiopaque markers. Nontarget tissues showed no device-related changes. CONCLUSIONS: Implantation of the absorbable IVC filter in swine proved safe with no pulmonary emboli detected. There was complete to near-complete resorption of the filter polymer by 32 weeks with restoration of the normal appearance and structure of the IVC.
Authors: Clement J Grassi; Timothy L Swan; John F Cardella; Steven G Meranze; Steven B Oglevie; Reed A Omary; Anne C Roberts; David Sacks; Mark I Silverstein; Richard B Towbin; Curtis A Lewis Journal: J Vasc Interv Radiol Date: 2003-09 Impact factor: 3.464
Authors: Jeet Minocha; Ibrahim Idakoji; Ahsun Riaz; Jennifer Karp; Ramona Gupta; Howard B Chrisman; Riad Salem; Robert K Ryu; Robert J Lewandowski Journal: J Vasc Interv Radiol Date: 2010-10-28 Impact factor: 3.464
Authors: Eric K Shang; Derek P Nathan; Jeffrey P Carpenter; Ronald M Fairman; Benjamin M Jackson Journal: Vasc Endovascular Surg Date: 2011-01-28 Impact factor: 1.089
Authors: Jeremy C Durack; Antonio C Westphalen; Stephanie Kekulawela; Shiv B Bhanu; David E Avrin; Roy L Gordon; Robert K Kerlan Journal: Cardiovasc Intervent Radiol Date: 2011-03-30 Impact factor: 2.740
Authors: Paul D Stein; Majd Alnas; Elias Skaf; Fadi Kayali; Tehmina Siddiqui; Ronald E Olson; Kiritkumar Patel Journal: Am J Cardiol Date: 2004-10-15 Impact factor: 2.778
Authors: William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell Journal: Chest Date: 2008-06 Impact factor: 9.410
Authors: Steven Y Huang; Jossana A Damasco; Li Tian; Linfeng Lu; Joy Vanessa D Perez; Katherine A Dixon; Malea L Williams; Megan C Jacobsen; Stephen J Dria; Mitchell D Eggers; Adam D Melancon; Rick R Layman; Elizabeth M Whitley; Marites P Melancon Journal: Biomater Sci Date: 2020-06-19 Impact factor: 6.843